These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 1681843

  • 1. Cell transformation by the epidermal growth factor receptor and v-erbB.
    Hayman MJ, Enrietto PJ.
    Cancer Cells; 1991 Aug; 3(8):302-7. PubMed ID: 1681843
    [Abstract] [Full Text] [Related]

  • 2. Ligand-independent oncogenic transformation by the EGF receptor requires kinase domain catalytic activity.
    Danielsen AJ, Maihle NJ.
    Exp Cell Res; 2002 Apr 15; 275(1):9-16. PubMed ID: 11925101
    [Abstract] [Full Text] [Related]

  • 3. Epidermal growth factor receptor (EGFR) signaling in cancer.
    Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR, Carotenuto A, De Feo G, Caponigro F, Salomon DS.
    Gene; 2006 Jan 17; 366(1):2-16. PubMed ID: 16377102
    [Abstract] [Full Text] [Related]

  • 4. The erbB gene and the EGF receptor.
    Martin GS.
    Cancer Surv; 1986 Jan 17; 5(2):199-219. PubMed ID: 2877733
    [Abstract] [Full Text] [Related]

  • 5. Analysis of structure and activation of some receptor-type tyrosine kinase oncogenes.
    Shibuya M, Matsushime H, Yamazaki H, Wang LH, Fukui Y, Ueyama Y, Tamaoki N.
    Princess Takamatsu Symp; 1986 Jan 17; 17():195-202. PubMed ID: 3455414
    [Abstract] [Full Text] [Related]

  • 6. Transcriptional regulation of signal regulatory protein alpha1 inhibitory receptors by epidermal growth factor receptor signaling.
    Kapoor GS, Kapitonov D, O'Rourke DM.
    Cancer Res; 2004 Sep 15; 64(18):6444-52. PubMed ID: 15374953
    [Abstract] [Full Text] [Related]

  • 7. Mutational analysis of the role of the carboxy-terminal region of the v-erbB protein in erythroid cell transformation.
    Lee EB, Beug H, Hayman MJ.
    Oncogene; 1993 May 15; 8(5):1317-27. PubMed ID: 8097581
    [Abstract] [Full Text] [Related]

  • 8. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
    Lehtola L, Sistonen L, Koskinen P, Lehväslaiho H, Di Renzo MF, Comoglio PM, Alitalo K.
    J Cell Biochem; 1991 Jan 15; 45(1):69-81. PubMed ID: 1706346
    [Abstract] [Full Text] [Related]

  • 9. EGF promotes in vivo tumorigenic growth of primary chicken embryo fibroblasts expressing v-myc and enhances in vitro transformation by the v-erbA oncogene.
    Khazaie K, Panayotou G, Aguzzi A, Samarut J, Gazzolo L, Jurdic P.
    Oncogene; 1991 Jan 15; 6(1):21-8. PubMed ID: 1671532
    [Abstract] [Full Text] [Related]

  • 10. Membrane localization of v-ErbB is required but not sufficient for ligand-independent transformation.
    Danielsen AJ, Christensen TA, Lovejoy CA, Adelsman MA, Connolly DC, Maihle NJ.
    Exp Cell Res; 2004 Jun 10; 296(2):285-93. PubMed ID: 15149858
    [Abstract] [Full Text] [Related]

  • 11. Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations.
    Cai CQ, Peng Y, Buckley MT, Wei J, Chen F, Liebes L, Gerald WL, Pincus MR, Osman I, Lee P.
    Oncogene; 2008 May 15; 27(22):3201-10. PubMed ID: 18193092
    [Abstract] [Full Text] [Related]

  • 12. Signal transduction cascade shared by epidermal growth factor and platelet-derived growth factor is a major pathway for oncogenic transformation in NRK cells.
    Masuda A, Kizaka-Kondoh S, Miwatani H, Terada Y, Nojima H, Okayama H.
    New Biol; 1992 May 15; 4(5):489-503. PubMed ID: 1515413
    [Abstract] [Full Text] [Related]

  • 13. Retroviral capture of c-erbB proto-oncogene sequences: rapid evolution of distinct viral genomes carrying mutant v-erbB genes with different transforming capacities.
    Vennström B, Raynoscheck C, Jansson L, Doederlein G, Lhotak V, Johnsson A, Beug H.
    Oncogene; 1994 May 15; 9(5):1307-20. PubMed ID: 8152791
    [Abstract] [Full Text] [Related]

  • 14. Rational bases for the development of EGFR inhibitors for cancer treatment.
    Bianco R, Gelardi T, Damiano V, Ciardiello F, Tortora G.
    Int J Biochem Cell Biol; 2007 May 15; 39(7-8):1416-31. PubMed ID: 17596994
    [Abstract] [Full Text] [Related]

  • 15. Kinase-deficient neu proteins suppress epidermal growth factor receptor function and abolish cell transformation.
    Qian X, Dougall WC, Hellman ME, Greene MI.
    Oncogene; 1994 May 15; 9(5):1507-14. PubMed ID: 7908733
    [Abstract] [Full Text] [Related]

  • 16. The epidermal growth factor receptor: from mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia.
    Arteaga CL.
    J Clin Oncol; 2001 Sep 15; 19(18 Suppl):32S-40S. PubMed ID: 11560969
    [Abstract] [Full Text] [Related]

  • 17. The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies.
    Dougall WC, Qian X, Peterson NC, Miller MJ, Samanta A, Greene MI.
    Oncogene; 1994 Aug 15; 9(8):2109-23. PubMed ID: 7913542
    [Abstract] [Full Text] [Related]

  • 18. Six amino acids from the retroviral gene gag greatly enhance the transforming potential of the oncogene v-erb-B.
    Bruskin A, Jackson J, Bishop JM, McCarley DJ, Schatzman RC.
    Oncogene; 1990 Jan 15; 5(1):15-24. PubMed ID: 1969616
    [Abstract] [Full Text] [Related]

  • 19. Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor.
    Alvarez JV, Greulich H, Sellers WR, Meyerson M, Frank DA.
    Cancer Res; 2006 Mar 15; 66(6):3162-8. PubMed ID: 16540667
    [Abstract] [Full Text] [Related]

  • 20. Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer.
    Amann J, Kalyankrishna S, Massion PP, Ohm JE, Girard L, Shigematsu H, Peyton M, Juroske D, Huang Y, Stuart Salmon J, Kim YH, Pollack JR, Yanagisawa K, Gazdar A, Minna JD, Kurie JM, Carbone DP.
    Cancer Res; 2005 Jan 01; 65(1):226-35. PubMed ID: 15665299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.